PPH VanEck Pharmaceutical ETF Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
18:33
Aug 05
Aug 05
Pharma offers AI upside and defense.
Pharmaceuticals are an underappreciated AI beneficiary with yield and strong balance sheets, offering a defensive play at a time when AI-driven drug discovery could compress development timelines and enhance productivity significantly.
HIGH
21:29
Jan 09
Jan 09
Recently added drug stocks to portfolio.
He says they recently added some drug stocks, though he does not name specific companies or give a detailed rationale.
LOW
00:28
Jan 06
Jan 06
Drug stocks on sale today
Cramer said drug stocks were on sale today and that he likes to watch declines to find good entry points. He used the group's selloff as the setup before naming his preferred names.
MED
About PPH Investor Commentary
Across the available history and selected sources, Buzzberg tracks PPH (VanEck Pharmaceutical ETF) across 3 sources: 4 bullish vs 0 bearish calls from 4 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 4 total trade ideas tracked. Latest voices: Sarah Ketterer, Richard Saperstein, Jim Cramer.